Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

DGMT StemCell supplies for E0787301 & E0221001

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This contract involves the procurement of medium supplies specifically intended to support the PHCE project E0787301 and the NTP project E221001. The supplies are related to DGMT stem cell materials, falling under the NAICS code 325414, which pertains to pharmaceutical preparation manufacturing. The contract is managed by the Food and Drug Administration, although specific location details for the office and place of performance are not provided. The solicitation is a forecast type and does not have a set-aside designation, indicating it may be open to a broad range of suppliers. Key points of contact include the NCTR Acquisition Liaison, who can be reached via email, while the contracting officer has not yet been determined. This contract aims to ensure the necessary stem cell supplies are available to support the related research and development projects within the FDA. Additional details and updates are accessible through the FDA's industry opportunity forecast portal.

General Info

Procurement of DGMT stem cell supplies for PHCE and NTP projects by FDA, open solicitation.

Agency

Food and Drug Administration → Food And Drug Administration

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing View NAICS

Place of Performance

US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyFood and Drug Administration → Food And Drug Administration
Contacts2 people available
OfficeN/A
Organization / Agency
Food and Drug Administration → Food And Drug Administration
Office AddressN/A
Contacts
Nctr Acquisition Liaison
To Be Determined To Be DeterminedContracting Officer

Full Description

Show more
This contract is for medium supplies to support PHCE project E0787301 & NTP project E221001

Similar Contracts

NAICS: 325414
New
Federal
iNDI FA13.1J Cell Lines Expansion and Distribution for the iPSC Neurodegenerative Disease Initiative (iNDI) ProjectThe Department of Health and Human Services, through the National Institutes of Health's National Institute on Aging, intends to award a sole source contract to The Jackson Laboratory for the expansion, quality control, biobanking, and distribution of isogenic Alzheimer’s disease and related dementias induced pluripotent stem cell lines as part of the iPSC Neurodegenerative Disease Initiative (iNDI) Project. This contract will focus on providing up to 936 specific iPSC lines, including 486 FA13.1J female SNV lines and 450 lines across 25 high-priority SNV trios, adhering to iNDI protocols for quality and expansion. The Jackson Laboratory is uniquely qualified for this contract as it currently houses the existing distribution infrastructure and has demonstrated successful past performance in supporting NIH’s iNDI requirements. The contract is planned to be a firm-fixed-price agreement with a performance period starting September 1, 2026, for a base year and up to three option years, ending August 31, 2030. The primary place of performance will be the contractor’s facility in Bar Harbor, Maine. While this notice signals the intent for a sole source award, other capable sources may submit capability statements demonstrating their ability to meet the outlined requirements, including supply of the specific cell lines, adherence to quality protocols, product and web content creation, and public distribution via an established platform. Responses must be submitted electronically by June 23, 2026, and the Government reserves the right to consider all responses but is under no obligation to initiate a competitive procurement.
National Institutes Of Health Olao

POSTED

about 21 hours ago

DEADLINE

in 12 days
View Details